Pap smear and cervical cancer in transgender men: integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i2.12342

Keywords:

Transgender persons; Uterine cervical neoplasms; Papanicolaou test.

Abstract

Introduction: Pap smear is the main screening method for cervical cancer, which can affect transgender men who have this organ. Objective: To highlight the importance of cytopathological examination in the fight against cervical cancer in transgender men. Methodology: It is an integrative literature review of a descriptive nature and qualitative approach, carried out on the SciELO, PUBMED, MEDLINE, LILACS, VHL and Science Direct databases, using the descriptors "Transgender Persons", "Uterine Cervical Neoplasms" and "Papanicolaou Test". Articles from 2015 to 2020 that address Pap smear and cervical cancer or cancer precursor lesions in transgender men were included. The analysis took place through critical reading and thematic categorization. Results and discussion: Eight articles were found that originated three categories: Screening for cervical cancer in transgender men, history related to the Pap smear and perceptions about screening for cervical cancer. Thus, it was found that transgender men do not screen for cervical cancer like cisgender women and face unique challenges in the Pap smear, relevant to each reality, leading them to seek alternatives that minimize their discomfort. Conclusion: The data reveal the importance of the Pap smear in the screening of cervical cancer in transgender men, since compared to alternative means sought, it is the most reliable today. Still, they reinforce the need for knowledge for individualized screening in this audience.

References

Adkins, B. D., Barlow, A. B., Jack, A., Schultenover, S. J., Desouki, M. M., Coogan, A. C., & Weiss, V. L. (2018). Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: challenges in detecting dysplasia. Cytopathology, 29(3), 281-287.

Agénor, M., Hughto, J. M., Peitzmeier, S. M., Potter, J., Deutsch, M. B., Pardee, D. J., & Reisner, S. L. (2018). Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults. Journal of General Internal Medicine, 33(7), 1015-1017.

Agénor, M., Peitzmeier, S. M., Bernstein, I. M., McDowell, M., Alizaga, N. M., Reisner, S. L., Pardee, D. J., & Potter, J. (2016). Perceptions of cervical cancer risk and screening among transmasculine individuals: Patient and provider perspectives. Culture, Health & Sexuality, 18(10), 1192-1206.

Beswick, A.; Corkum, M.; D’Souza, D. (2019). Locally advanced cervical cancer in a transgender man. Canadian Medical Association Journal, 191(3), E76-E78.

Harb, C. Y. W., Pass, L. E., Soriano, I. C., Zwick, A., & Gilbert, P. A. (2019). Motivators and Barriers to Accessing Sexual Health Care Services for Transgender/Genderqueer Individuals Assigned Female Sex at Birth. Transgender Health, 4(1), 58-67.

Instituto Nacional de Câncer. (2020). Tipos de câncer: câncer do colo do útero. Recuperado em 01 maio, 2020, de https://www.inca.gov.br/tipos-de-cancer/cancer-do-colo-do-utero

Instituto Nacional de Câncer José Alencar Gomes da Silva. (2016). Diretrizes brasileiras para o rastreamento do câncer de colo do útero/Instituto Nacional de Câncer José Alencar Gomes da Silva, Coordenação de Prevenção e Vigilância, Divisão de Detecção Precoce e Apoio à Organização de Rede. Rio de Janeiro: INCA, 32-34. Recuperado em 01 maio, 2020, de https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//diretrizesparaorastreamentodocancerdocolodoutero_2016_corrigido.pdf

Johnson, M. J., Mueller, M., Eliason, M. J., Stuart, G., & Nemeth, L. S. (2016). Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men. Journal of Clinical Nursing, 25(23-24), 3628-3642.

Lam, J. S. H., & Abramovich, A. (2019). Transgender-inclusive care. Canadian Medical Association Journal, 191(3), E79.

Mcdowell, M., Pardee, D. J., Peitzmeier, S., Reisner, S. L., Agénor, M., Alizaga, N., Bernstein, I., & Potter, J. (2017). Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health, 4(4), 252-259.

Monteiro, S., Brigeiro, M., & Barbosa, R. M. (2019). Saúde e direitos da população trans. Cadernos de Saúde Pública, 35(4), 1-4.

Peitzmeier, S. M., Agénor, M., Bernstein, I. M., McDowell, M., Alizaga, N. M., Reisner, S. L., Pardee, D. J., & Potter, J. (2017). “It can promote an existential crisis”: factors influencing Pap test acceptability and utilization among transmasculine individuals. Qualitative Health Research, 27(14), 2138-2149.

Peitzmeier, S. M., Reisner, S. L., Harigopal, P., & Potter, J. (2014). Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. Journal of General Internal Medicine, 29(5), 778-784.

Seay, J., Ranck, A., Weiss, R., Salgado, C., Fein, L., & Kobetz, E. (2017). Understanding transgender men's experiences with and preferences for cervical cancer screening: a rapid assessment survey. LGBT Health, 4(4), 304-309.

Silva, R. C. G., Silva, A. C. O., Peres, A. L., & Oliveira, S. R. (2018). Perfil de mulheres com câncer de colo do útero atendidas para tratamento em centro de oncologia. Revista Brasileira de Saúde Materno Infantil, 18(4), 703-710.

Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Revisão integrativa: o que é e como fazer. Einstein, 8(1), 102-106.

Published

09/02/2021

How to Cite

ARAÚJO, J. M. da S. .; SANTOS, M. M. G. .; SILVA, R. S. da .; MARTINS, M. de C. V.; GALLOTTI, F. C. M. . Pap smear and cervical cancer in transgender men: integrative review. Research, Society and Development, [S. l.], v. 10, n. 2, p. e17010212342, 2021. DOI: 10.33448/rsd-v10i2.12342. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/12342. Acesso em: 25 apr. 2024.

Issue

Section

Health Sciences